Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Retraction
IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,580 | Dovepress* | 2,515+ | 135 | 2,650 | |
| PubMed Central* | 65 | 28 | 93 | ||
| Totals | 2,580 | 163 | 2,743 | ||
| *Since 22 August 2022 | |||||
View citations on PubMed Central and Google Scholar